Aavantgarde

Website

Developer of a gene therapy technology designed for inherited retinal disorders. The company builds on proprietary Adeno-Associated Viral (AAV) vector platforms to address the gene therapy cargo capac...

Healthcare
Rome, Italy
Founded 2021
27 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$211.4M
Last Round
N/A
Investors
+14 other investors
View all 14 investors
Valuation History
0 funding rounds on record
Cap Table
Ownership structure
Market Activity
Secondary transactions

Get the full picture

Create a free account to unlock Aavantgarde's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required